Our finding that PKD1 mutations confer an ≈8.5-fold increased risk of LVH, independent of hypertension, age, sex and anaemia, strongly supports the hypothesis that intrinsic mechanisms related to polycystin-1 dysfunction directly impact myocardial structure or function. This evidence concerns the gene PKD1 and hypertensive disorder.